14 results
10-Q
2020 Q3
TARS
Tarsus Pharmaceuticals Inc
24 Nov 20
Quarterly report
9:27pm
ability to recoup our investment in one or more product candidates, even if such product candidates obtain marketing approval.
Failure to comply
10-K
pqon25g2emp 92op8o
31 Mar 21
Annual report
5:01pm
ARS
5bij0ar1
26 Apr 23
Annual report to shareholders
4:08pm
ARS
y4nn 4euh
26 Apr 24
Annual report to shareholders
4:27pm
S-1/A
fknelaf4z7xdcqhpogz
9 Oct 20
IPO registration (amended)
5:16pm
S-1
h267iyeplh lk0zy0
25 Sep 20
IPO registration
5:25pm
DRS/A
1tf26nrem1eh84 0ixtf
14 Sep 20
Draft registration statement (amended)
12:00am
424B4
w4ccbsa2j27nu s2z
16 Oct 20
Prospectus supplement with pricing info
4:40pm
DRS
l5wpcg8nssb58b
7 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next